This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Allergan, Kythera Biopharmaceuticals to file US antitrust paperwork within 15 business days

( June 17, 2015, 14:23 GMT | Official Statement) -- MLex Summary: Global pharmaceutical company Allergan and Kythera Biopharmaceuticals will file paperwork with US antitrust authorities within 15 business days of their June 17 merger agreement, according to a Kythera  filing with the US Securities and Exchange Commission on Wednesday. Allergan is planning to buy Kythera Biopharmaceuticals for $2.1 billion. The companies are expected to file paperwork by July 8.Extract....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login